Table 3.

Summary of current data for antiplatelet therapy in stroke prevention.

  • ▪ Aspirin better than placebo

  • ▪ No evidence of greater effectiveness of high-dose aspirin compared to low-dose aspirin

  • ▪ Aspirin plus extended-release dipyridamole (ER-DP) more effective than aspirin alone

  • ▪ Clopidogrel more effective than aspirin alone

  • ▪ Aspirin plus clopidogrel no more effective than clopidogrel alone, but with substantially more bleeding

  • ▪ Aspirin plus ER-DP and clopidogrel equivalent, but slightly more bleeding with aspirin plus ER-DP

 
  • ▪ Aspirin better than placebo

  • ▪ No evidence of greater effectiveness of high-dose aspirin compared to low-dose aspirin

  • ▪ Aspirin plus extended-release dipyridamole (ER-DP) more effective than aspirin alone

  • ▪ Clopidogrel more effective than aspirin alone

  • ▪ Aspirin plus clopidogrel no more effective than clopidogrel alone, but with substantially more bleeding

  • ▪ Aspirin plus ER-DP and clopidogrel equivalent, but slightly more bleeding with aspirin plus ER-DP

 

or Create an Account

Close Modal
Close Modal